Top Tech Companies in Boston, MA (4,693)

Strong Revenue Growth: Inc. 5000 recognitions cite 82% and 72% three-year growth, and investor disclosures note meaningful 2025 revenue scale, indicating sustained multi-year expansion. While precise YoY rates aren’t public, repeated list appearances and disclosed scale point to continued momentum.

Investor Backing & Capital Strength: Nordic Capital became the majority owner in 2025 to support the next phase of growth, expansion, and platform investment. Additional financing and stated plans for strategic acquisitions further reinforce access to growth capital.

Market Expansion: Customer and data footprint expanded to 170M+ patient records across 200+ provider/payer organizations, with more than 2.25M value-based lives added in 2024. Management and media describe ambitions for further expansion via M&A and potential moves beyond the U.S.

Strong Revenue Growth: Results show sustained low- to mid‑20s year‑over‑year expansion, including roughly 23% in Q2 2026 and 24% for full‑year 2025. Guidance points to continued double‑digit growth in recurring gross profit.

Profitability: Financial disclosures indicate rising GAAP profitability, with Q2 2026 net income increasing to about $154 million and adjusted EBITDA stepping up alongside raised full‑year targets. Profit growth is occurring in tandem with expanding scale across ARR, locations, and GPV.

Strong Market Position & Advantage: Evidence characterizes the company as a leading U.S. restaurant‑focused platform with approximately 180,000 locations, record quarterly net adds, and notable enterprise wins and partnerships. Scale in locations and GPV reinforces competitive positioning within restaurant technology and payments.

Customer Loyalty & Retention: Autoship accounts for the vast majority of sales (over four-fifths) and is growing faster than total revenue, indicating a sticky, recurring base and higher retention. Evidence includes Autoship representing ~83% of FY2025 net sales and ~84.6% in Q2 FY2026 with high single‑digit to double‑digit growth.

Profitability: Operating metrics show expanding earnings power, with adjusted EBITDA up materially and margins improving alongside strong free cash flow. Observations include FY2025 adjusted EBITDA growth of ~26% with margin expansion and additional year‑over‑year gains reported in 1H FY2026.

Strong Market Position & Advantage: Chewy is characterized as the largest U.S. pet e‑tailer and a leading online pet‑supplies platform by GMV and digital presence, underpinning durable scale advantages. Multiple summaries highlight leadership in online pet retail, substantial Autoship penetration, and strong digital search share versus specialty peers.

Profitability: Operating income has risen materially alongside growth, with the latest quarter reporting meaningful GAAP and adjusted operating profits and expanding margins. This indicates the business is scaling while improving earnings quality.

Resilient & Sustainable Growth: Gross profit is expanding at a strong, accelerating pace, with both Cash App and Square contributing and management raising full‑year outlooks. Longer‑term disclosures also highlight multi‑year compounding in gross profit per user across ecosystems.

Cost & Operational Efficiency: A leaner organizational structure and disciplined spending have driven record adjusted operating margins and improved operating leverage. Efficiency gains appear to be a second engine alongside revenue drivers.

Strong Revenue Growth: Revenue increased 19% in 2025 and accelerated in 2026 with 22% year-over-year growth in Q1 and 27% in Q2, while first-half 2026 revenue rose 25% year over year. Management raised full-year 2026 guidance to $94–96M, implying roughly 22–24% growth.

Customer Loyalty & Retention: Net Dollar Retention reached 117% in Q1 2026, indicating expanding spend from existing accounts after churn. Core genomics customers rose to 537 as of March 31, 2026, with record new customer additions in 2025.

Market Expansion: Geographic momentum is evident with Q1 2026 analysis volume up 28% in the U.S. and 31% in APAC, and EMEA revenue up 30%. Platform usage set records (e.g., 108,000 analyses in Q1 and 115,000 in Q2), with liquid biopsy volumes growing sharply.

Investor Backing & Capital Strength: Capital resources include a $100M social bond, audited net asset growth in 2025, and $118M of impact investments deployed over four years. These signals indicate ample capacity to fund programs and expansion.

Market Expansion: Activities include the 2026 acquisition of Lab4U, scaling of Education at Work, and reported reach of 15M+ young people annually. Continued initiatives and campaigns following the 2026 rebrand point to a widening footprint.

Strategic Partnerships: Collaborations span major field builders and funders, such as the Britebound Center for Career Navigation at JFF and a grantee community of 100+ organizations across 49 states and Puerto Rico. These ties support national presence and program scaling.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.

Strong Hiring & Retention: Staffing is budgeted to rise from 1,276 FTE in 2024 to 1,321 in 2025, and the Bank reported 125 new hires in 2024. These data point to continued investment in personnel to support core responsibilities.

Future-Ready Strategy: Operating resources are set to expand, with a 2025 budget of $460.0M versus $431.0M in 2024 actuals, alongside stepped-up technology and facilities investments. The institution emphasizes modernization of payments infrastructure (e.g., FedNow) and systems as part of this plan.

Innovation-Driven Growth: Leadership in instant payments (FedNow), ongoing payments initiatives, and active research series through 2026 highlight expansion anchored in innovation. New structures such as the First District Payments Advisory Council reinforce its role in evolving the payments landscape.

Strong Revenue Growth: ARR increased from $177M in 2024 to $218M in 2025, with reported ARR roughly doubling since 2021. Platform activity also expanded as GMV rose from $11.2B to about $14.6–$15B over the same period.

Profitability: The group was profitable throughout 2025, following earlier profitability in the core Platform business. This progression indicates improving operating leverage alongside continued expansion.

Diversified Revenue Streams: Newer products are contributing incremental revenue, with Mirakl Connect generating about $11.7M ARR in under a year and Mirakl Ads seeing a sharp rise in ad spend in 2025. Customer additions (45 global enterprises in 2025) and launches across marketplace and dropship broaden the commercial base.

Strong Revenue Growth: Reported results show revenue rising from $3.67B (2023) to $4.77B (2024) to $6.05B (2025), with early 2026 revenue and guidance pointing to further gains. Q1 2026 continued to grow year over year, alongside expanding sportsbook handle and average monthly payers.

Profitability: Reported results show Adjusted EBITDA improving from $181M (2024) to $620M (2025) and a shift to positive GAAP net income in 2025. Guidance indicates substantial Adjusted EBITDA for 2026.

Product Line Growth: Company disclosures describe rising iGaming revenue in 2025 and the launch of new offerings like Predictions and a consolidated “super app.” These additions broaden the business beyond traditional sportsbook and DFS.

Strong Market Position & Advantage: Ekotrope is positioned as the most widely used HERS rating software in the U.S., supporting roughly 1 in 4 new homes and serving 7,000+ builders with 400,000+ homes per year. Penetration spans hundreds of HERS rating companies and more than 40 utility new‑construction programs.

Investor Backing & Capital Strength: An $11M financing in October 2025, bringing tracked cumulative funding to about $15.9M, underscores continued capital support for expansion. Multiple independent profiles indicate the company has raised additional capital over time rather than a single one‑off event.

Product Line Growth: The company has expanded beyond its core RATER tool into Market Intelligence data products and solutions for utilities, builders, manufacturers, and lenders. Release history shows major version updates (e.g., Version 5.0 in 2025 with additional releases in 2026), indicating an active roadmap.

Strong Revenue Growth: Revenue grew 26% year over year in FY2024. ARR increased 30% in 2023 after crossing the $100M threshold in 2022.

Profitability: Operations remained profitable and cash‑flow positive in FY2024 while the organization expanded to just under 600 employees.

Investor Backing & Capital Strength: A July 2024 majority investment led by Vista Equity Partners (with TCV and KKR) valued the company at about $1.2B. This reflects substantial external capital support for continued expansion.

Strong Revenue Growth: Recent results show revenue rising from $1.62B in FY2023 to $2.17B in FY2024, $2.67B in FY2025, and about $3.35B in FY2026, with Q4 FY2026 up 25% year over year. This trajectory, alongside mid‑20% ARR growth, indicates continued expansion rather than a stall.

Healthy Cash Flow: Cash generation is growing, with free cash flow rising to about $779M in FY2026 and a free‑cash‑flow margin near 23%. Non‑GAAP operating metrics, including an ~80% gross margin, underscore operating leverage.

Strong Market Position & Advantage: Industry evaluations list the company as a Leader in the 2026 Gartner Magic Quadrants for both SSE and SASE, with five consecutive years of SSE leadership. Expanding large‑enterprise adoption and thousands of customers support a durable position in its core zero trust/SSE markets.

Strong Market Position & Advantage: Adoption spans 1,300+ biotechnology organizations with usage reported across more than half of the top 50 biopharma companies, signaling durable positioning in life‑sciences R&D software. Multiple sources characterize the platform as a leading life‑sciences R&D cloud used by both startups and major enterprises.

Product Line Growth: The company continues to launch and expand major offerings, including Benchling AI, antibody‑discovery capabilities, automation/analysis tools, and extensions into new scientific workflows such as small‑molecule chemistry. Acquisitions like PipeBio further broaden capability depth in biologics and related R&D domains.

Innovation-Driven Growth: AI is a clear growth vector, with reports that 500 biotech companies used Benchling AI in its first year and the product subsequently reached general availability. Team acquisitions (e.g., ReSync Bio and Sphinx Bio) and partnerships (e.g., with Anthropic) underscore a deliberate push to embed advanced models into scientific workflows.

Profitability: Net income rose to $6.79B in 2025 from $4.38B in 2024. The combined ratio improved materially (e.g., S&P-adjusted 89.7% in 2025 and high-80s in early 2026), indicating stronger underwriting performance.

Investor Backing & Capital Strength: Shareholders’ equity increased from about $22.2B in 2022 to $39.9B at year-end 2025 and exceeded $44B by mid-2026. External ratings actions (AM Best A affirmation in Sept 2025; S&P upgrade to A+ in July 2026) underscore improved capitalization.

Resilient & Sustainable Growth: S&P describes deliberate portfolio reshaping and expects 2–3% annual premium growth during 2026–2028. Management emphasizes disciplined, selective expansion following underwriting improvements, prioritizing durable returns over sheer volume.

Investor Backing & Capital Strength: Funding reached a $200M Series C in July 2024 at a $1B valuation with prominent investors. Available evidence suggests substantial capital to scale and strong external confidence.

Market Expansion: Engagements extended across governments and enterprises, including the UK’s £8M three-year program, a CBP contract expansion, and new deployments with General Atomics Aeronautical Systems and Scarbrough Global; by 2026, the company said 8 of the world’s 10 largest logistics providers were customers. These signals indicate continued penetration into large, international accounts and public-sector programs.

Product Line Growth: The offering broadened beyond supply-chain mapping into compliance, procurement, trade-risk management, and customs-automation workflows, including the 2026 Cervo AI acquisition. 2025–2026 materials describe additional use cases and live customer deployments.

Strong Revenue Growth: Revenue is scaling at strong double-digit rates, reaching $702M in FY2026 and continuing to rise in subsequent quarters, with full‑year FY2027 guidance lifted into the low‑$900M range. Multiple updates indicate momentum in both reported results and outlook.

Healthy Cash Flow: Operating cash flow turned positive in FY2026 and free cash flow was also positive, alongside progress in non‑GAAP profitability in later quarters. These milestones suggest improving financial efficiency as scale increases.

Diversified Customer Base: The company reports 12,500+ active customers and continued wins with large enterprises across technology, manufacturing, and healthcare. This breadth points to demand resilience across multiple industries.

Strong Revenue Growth: Bookings are reported to have grown 103% year over year in 2025, exiting at a roughly $1.1B annualized run rate, indicating rapid top-line momentum. Additional signals such as sustained wholesale growth reinforce that commercial scale is accelerating.

Healthy Cash Flow: Operations are described as cash-flow positive in 2025 while growth accelerated, suggesting improving financial sustainability alongside expansion. This combination points to scaling that is not purely subsidized by burn.

Investor Backing & Capital Strength: A $575M Series G at a $10.1B valuation underscores substantial access to capital and confidence from prominent investors. This financing is framed as enabling continued international expansion and hiring.

Strong Revenue Growth: Company disclosures cite strong year-over-year revenue growth in 2025 with annualized revenue surpassing $300M, and later coverage describes revenue nearing $400M annualized in 2026. This points to rapid scaling from 2023 through 2026.

Investor Backing & Capital Strength: Recent financings include a $200M Series E at a $2.7B valuation and a $300M private credit facility, with third-party trackers noting over $1B raised across multiple rounds. This capital base is positioned to fund continued product and geographic expansion.

Market Expansion: The company launched its Spend product in the U.S. and indicated the market already represents a substantial share of new business, while also opening new international locations. These moves signal broadening global reach and demand.

Strong Revenue Growth: Available evidence indicates sustained top-line expansion, with company-reported growth corroborated by repeated placements on independent fast-growth lists such as the Inc. 5000 and the Financial Times’ Americas ranking. These signals collectively point to continuing revenue momentum rather than a one-off spike.

Strong Hiring & Retention: Headcount has increased substantially since 2021, with recent statements describing ongoing hiring and acceleration year over year. Active postings across Cloud Engineering, ServiceNow, and related roles further indicate expansion of the workforce.

Market Expansion: The company extended its footprint beyond North America into EMEA and later into APAC, including initial hires in Australia. Growth in delivery activity and practice presence across these regions suggests a broader market reach.